Myth that insulin is last resort unfounded
Posted on: Monday, 17 August 2009, 23:50 CDT
Type 2 diabetics often resist insulin fearing weight gain, poor quality of life or low blood sugar, but U.S. researchers say such fears are largely unfounded.
Researchers at the University of Texas Southwestern Medical Center suggest patients and physicians should consider insulin as a front-line defense, as opposed to a treatment of last resort for non-insulin-dependent diabetes.
We found that those patients who received insulin initially did just as well, if not better, than those who didn't receive insulin,
lead author Dr. Ildiko Lingvay says in a statement. This reinforces the idea that insulin treatment is a viable and safe option for patients, even in the very initial stages of their diagnoses.
The researchers compared rates of compliance, satisfaction, effectiveness, safety and quality of life among the patients, who were randomized to receive either standard triple oral therapy or insulin plus metformin -- an oral drug that helps regulate blood sugar levels.
The study, scheduled to be published in Diabetes Care, finds patients taking insulin plus metformin had fewer low-blood-sugar, or hypoglycemic, events, gained less weight and reported high satisfaction with the insulin.
Source: United Press International
Related Articles
- New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions
- New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone
- Patient’s Manage High Blood Pressure Over the Internet
- BD Announces FDA 510(K) Clearance of Two-Hour Test to Identify Superbug in Patients With Positive Blood Cultures
- Market Research Suggests Internet Recruitment Is Reducing Clinical Trial Costs; 85 Percent of Patients Research Ailments Online
- Exforge(R) Receives Final US Approval As New and Powerful Treatment Option for Patients With High Blood Pressure
- Exforge(R) Receives US Regulatory Approval As a New and Highly Effective Treatment Option for Patients With High Blood Pressure
- Patients, Researchers Confront Long-Term Effects of West Nile
- Tampa General Hospital Approved to Enroll Patients in Synthetic Blood International's Phase II Oxycyte Trial
- Lowering BP With Medication Provides Unexpected Benefits for Heart Disease Patients With 'Normal' Blood Pressure
 |
 |
User Comments (0)
RSS Feeds